AU2002217356A1 - Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient - Google Patents
Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredientInfo
- Publication number
- AU2002217356A1 AU2002217356A1 AU2002217356A AU1735602A AU2002217356A1 AU 2002217356 A1 AU2002217356 A1 AU 2002217356A1 AU 2002217356 A AU2002217356 A AU 2002217356A AU 1735602 A AU1735602 A AU 1735602A AU 2002217356 A1 AU2002217356 A1 AU 2002217356A1
- Authority
- AU
- Australia
- Prior art keywords
- sup
- sub
- novel
- group
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- RPBDCDQMCRHNLM-UHFFFAOYSA-N C1=NNC=C2C=CC=CC2=C1 Chemical class C1=NNC=C2C=CC=CC2=C1 RPBDCDQMCRHNLM-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
The invention refers to novel 2,3-benzodiazepine derivatives of formula (I) and pharmaceutical compositions containing the same as the active ingredient. The novel compounds antipasmodic, muscle relaxant and neuroprotective activities. In formula I; X represents a hydrogen atom, a chloro atom or a methoxy group; Y stands for a hydrogen atom or a halo atom; Z means a methyl group or a chloro atom; R is a C<SUB>1-4 </SUB>alkyl group or a group of the formula -NR<SUP>1</SUP>R<SUB>2</SUB>, wherein R<SUP>1 </SUP>and R<SUP>2 </SUP>represent, independently, a hydrogen atom, a C<SUB>1-4 </SUB>alkyl group, a C<SUB>1-4 </SUB>alkoxy group or a C<SUP>3-6 </SUP>cycloalkyl group.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0004994 | 2000-12-21 | ||
HU0004994A HU225100B1 (en) | 2000-12-21 | 2000-12-21 | 2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and their use |
PCT/HU2001/000151 WO2002050044A1 (en) | 2000-12-21 | 2001-12-19 | Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002217356A1 true AU2002217356A1 (en) | 2002-07-01 |
Family
ID=89978876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002217356A Abandoned AU2002217356A1 (en) | 2000-12-21 | 2001-12-19 | Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
Country Status (20)
Country | Link |
---|---|
US (1) | US7189711B2 (en) |
EP (1) | EP1351942B1 (en) |
JP (1) | JP4201252B2 (en) |
AT (1) | ATE271548T1 (en) |
AU (1) | AU2002217356A1 (en) |
BG (1) | BG66199B1 (en) |
CA (1) | CA2431761C (en) |
CZ (1) | CZ301371B6 (en) |
DE (1) | DE60104448T2 (en) |
DK (1) | DK1351942T3 (en) |
EA (1) | EA005867B1 (en) |
ES (1) | ES2225412T3 (en) |
HU (1) | HU225100B1 (en) |
PL (1) | PL211495B1 (en) |
PT (1) | PT1351942E (en) |
RO (1) | RO121268B1 (en) |
SK (1) | SK286620B6 (en) |
TR (1) | TR200402493T4 (en) |
UA (1) | UA74615C2 (en) |
WO (1) | WO2002050044A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0302449A3 (en) * | 2003-08-04 | 2005-06-28 | Egis Gyogyszergyar Nyilvanosan | 8-chloro-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for producing them |
JP2009522245A (en) * | 2005-12-30 | 2009-06-11 | エギシュ ヂョヂセルヂャール ニルヴァーノサン ミケデ レースヴェーニタールササーグ | Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
EA201590356A1 (en) * | 2012-08-16 | 2015-07-30 | Байер Фарма Акциенгезельшафт | 2,3-benzodiazepines |
CN105492436A (en) * | 2013-06-17 | 2016-04-13 | 拜耳制药股份公司 | Substituted phenyl-2,3-benzodiazepines |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU191698B (en) | 1984-07-27 | 1987-03-30 | Gyogyszerkutato Intezet | Process for producing new 1-aryl-5h-2beta-benzodiazepines |
HU219778B (en) * | 1990-12-21 | 2001-07-30 | Gyógyszerkutató Intézet Közös Vállalat | Process for producing n-acyl-2,3-benzodiazepine derivatives, their acid additional salts and pharmaceutical compositions containing them and a grop of the compounds and pharmaceutical compositions containing them |
DE19604920A1 (en) * | 1996-02-01 | 1997-08-07 | Schering Ag | New 2,3-benzodiazepine derivatives, their production and use as medicines |
US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
HU9600871D0 (en) * | 1996-04-04 | 1996-05-28 | Gyogyszerkutato Intezet | New 2,3-benzodiazepine derivatives |
HU227128B1 (en) * | 1999-07-07 | 2010-07-28 | Egyt Gyogyszervegyeszeti Gyar | New 2,3-benzodiazepine derivatives |
RU2325811C2 (en) | 2006-06-28 | 2008-06-10 | Общество С Ограниченной Ответственностью "Фито-Маг" | Method of storing fruits, vegetables and crop products |
-
2000
- 2000-12-21 HU HU0004994A patent/HU225100B1/en not_active IP Right Cessation
-
2001
- 2001-12-19 DE DE60104448T patent/DE60104448T2/en not_active Expired - Lifetime
- 2001-12-19 SK SK788-2003A patent/SK286620B6/en not_active IP Right Cessation
- 2001-12-19 TR TR2004/02493T patent/TR200402493T4/en unknown
- 2001-12-19 US US10/450,898 patent/US7189711B2/en not_active Expired - Fee Related
- 2001-12-19 CZ CZ20031680A patent/CZ301371B6/en not_active IP Right Cessation
- 2001-12-19 CA CA2431761A patent/CA2431761C/en not_active Expired - Fee Related
- 2001-12-19 PT PT01271364T patent/PT1351942E/en unknown
- 2001-12-19 EA EA200300691A patent/EA005867B1/en not_active IP Right Cessation
- 2001-12-19 AT AT01271364T patent/ATE271548T1/en not_active IP Right Cessation
- 2001-12-19 UA UA2003076874A patent/UA74615C2/en unknown
- 2001-12-19 JP JP2002551541A patent/JP4201252B2/en not_active Expired - Fee Related
- 2001-12-19 PL PL362029A patent/PL211495B1/en unknown
- 2001-12-19 DK DK01271364T patent/DK1351942T3/en active
- 2001-12-19 RO ROA200300539A patent/RO121268B1/en unknown
- 2001-12-19 AU AU2002217356A patent/AU2002217356A1/en not_active Abandoned
- 2001-12-19 EP EP01271364A patent/EP1351942B1/en not_active Expired - Lifetime
- 2001-12-19 WO PCT/HU2001/000151 patent/WO2002050044A1/en active IP Right Grant
- 2001-12-19 ES ES01271364T patent/ES2225412T3/en not_active Expired - Lifetime
-
2003
- 2003-06-20 BG BG107932A patent/BG66199B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ20031680A3 (en) | 2003-11-12 |
BG66199B1 (en) | 2012-01-31 |
HU0004994D0 (en) | 2001-03-28 |
WO2002050044A1 (en) | 2002-06-27 |
EA200300691A1 (en) | 2003-12-25 |
CA2431761C (en) | 2010-05-25 |
RO121268B1 (en) | 2007-02-28 |
HUP0004994A2 (en) | 2002-11-28 |
US7189711B2 (en) | 2007-03-13 |
BG107932A (en) | 2004-02-27 |
DE60104448D1 (en) | 2004-08-26 |
DK1351942T3 (en) | 2004-11-22 |
PL362029A1 (en) | 2004-10-18 |
DE60104448T2 (en) | 2005-07-28 |
US20040092510A1 (en) | 2004-05-13 |
EP1351942A1 (en) | 2003-10-15 |
SK286620B6 (en) | 2009-02-05 |
HU225100B1 (en) | 2006-06-28 |
ATE271548T1 (en) | 2004-08-15 |
CZ301371B6 (en) | 2010-02-03 |
SK7882003A3 (en) | 2003-11-04 |
JP2004516284A (en) | 2004-06-03 |
TR200402493T4 (en) | 2004-12-21 |
PL211495B1 (en) | 2012-05-31 |
CA2431761A1 (en) | 2002-06-27 |
JP4201252B2 (en) | 2008-12-24 |
PT1351942E (en) | 2004-11-30 |
UA74615C2 (en) | 2006-01-16 |
EP1351942B1 (en) | 2004-07-21 |
ES2225412T3 (en) | 2005-03-16 |
EA005867B1 (en) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001009103A3 (en) | Imidazole antiproliferative agents | |
MXPA02012033A (en) | 2-aminocarbonyl-9h-purine derivatives. | |
EP1253142A4 (en) | Compounds exhibiting thrombopoietin receptor agonism | |
EP1207155A4 (en) | Drug compositions exhibiting thrombopoietin agonism | |
IL124537A0 (en) | Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same | |
AU2001264474A1 (en) | Admantane derivatives | |
GB9905075D0 (en) | Chemical compounds | |
AU4257901A (en) | Triarylimidazole derivatives as cytokine inhibitors | |
CA2238430A1 (en) | Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives | |
MXPA04006322A (en) | 6-fluorobicyclo[3.1.0]hexane derivatives. | |
HK1004332A1 (en) | Dihalotriazolopyrimidine derivatives as fungicides | |
AU2001293826A1 (en) | Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors | |
AU4431200A (en) | 4'-c-ethynyl pyrimidine nucleosides | |
MXPA04011914A (en) | Modified release pharmaceutical formulation. | |
DE60117847D1 (en) | FARNESYL TRANSFERASE INHIBITING CHINOLIN AND CHINAZOLE DERIVATIVES SUBSTITUTED IN THE 4-POSITION | |
EP0765865A4 (en) | 2-acylaminopropanol compound and medicinal composition | |
NZ516100A (en) | Streptogramin derivatives, preparation and compositions containing them | |
HK1052697A1 (en) | Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same. | |
AU1366802A (en) | 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives | |
AU2002217356A1 (en) | Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient | |
WO2001051004A3 (en) | Anti-cancer agent containing naphthoquinone compound | |
DE60119383D1 (en) | FARNESYL TRANSFERASE-INHIBITING 4-HETEROCYCLYLCHINOLIN AND CHINAZOLINE DERIVATIVES | |
AU2002214056A1 (en) | Farnesyl transferase inhibiting benzoheterocyclic derivatives | |
WO2000024389A3 (en) | Benzoquinoline derivatives useful as antibacterial agents | |
CA2129813A1 (en) | 5-aminoflavone derivatives |